Atlas Trials

Clinical Trial of Avasopasem in Patients With Metastatic Hormone Receptor Positive Breast Cancer With Progression on a CDK 4/6 Inhibitor and Hormonal Therapy

Clinical trial NCT07137871 · RECRUITING

Trial details

NCT number
NCT07137871
Sponsor
The University of Texas Health Science Center at San Antonio
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Breast Cancer Metastatic
Start date
2025-10-02
Primary completion
2027-10-01
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.